(NasdaqGS:AMKR), we can see that the 12 month volatility is presently 35.201700. The 6 month volatility is 34.106700, and the 3 month is spotted at 30.906500. Engineers Gate Manager LP now owns 97,538 shares of the semiconductor company's stock worth $980,000 after acquiring an additional 45,349 shares during the last quarter. AMKR stock price lost -3.93% over the past year, yielding a negative weighted alpha of percent. $6.40's average target is -30.96% below currents $9.27 stock price. The company's product candidates include XmAb5871, an immune inhibitor, which is in Phase II clinical trials for the treatment of autoimmune diseases; XmAb7195, an immune inhibitor that is in Phase I clinical for use in treating asthma and allergic diseases; XmAb14045, a bispecific oncology candidate, which is in phase I clinical trials for the treatment of acute myeloid leukemia; and XmAb13676 that is in phase I clinical trials for the treatment of B-cell malignancies.
Other institutional investors have also bought and sold shares of the company. Investors may even choose to piece together the portfolio with stocks from different categories. They use historic price data to observe stock price patterns to predict the direction of that price going forward. AMKR price is down almost -24.43% from its 52-week high price of $12.48 a share but is up about 17.05% from its 52-week low price of $8.32 a share. The price index is calculated by dividing the current share price by the share price ten months ago. The price-to-sales ratio offers a simple approach in this case. EPS ratio determined by looking at last 12 month figures is -8.43. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.16 and a quick ratio of 0.92.
Several analysts have released their opinion on Amkor Technology, Inc.
Support is likely to come between $9.36 a share to $8.7 a share level. On the other end, a stock with a score from 0-2 would be viewed as weak. Zacks Investment Research cut shares of Amkor Technology from a hold rating to a sell rating in a research note on Wednesday, November 1st. (NasdaqGS:AMKR). The name now has a score of 30.00000. The current 6.41% margin seems to continue this movement, which could imply improved cost efficiency as well as increasing revenue contributed to the previous earnings growth. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.
Analysts expect Xencor, Inc. The Manufacturers Life Insurance Company grew its holdings in Amkor Technology by 2.8% during the 2nd quarter. The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity. Illinois-based Guggenheim Limited Company has invested 0% in CAS Medical Systems, Inc.
Multiple company employees have indulged in significant insider trading. This suggests future earnings growth is driven further by an increase in top line revenue, which is forcing down the percentage of net income retained from the growth in revenue. The Ohio-based Foster & Motley Inc has invested 0.53% in the stock. The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, "The Little Book that Beats the Market". Moreover the Company's Year To Date performance was -5.47%.
More recent Univar Inc. In general, and ADX value from 0-25 would represent an absent or weak trend. Amkor Technology now has an average rating of Hold and an average target price of $10.50. The 52-week range can be found in the stock's quote summary. More interesting news about Amkor Technology, Inc. (NasdaqGS:AMKR) is 0.458427. Free cash flow (FCF) is the cash produced by the company minus capital expenditure.
Dividends is a reward scheme, that a company presents to its shareholders.
The value of a stock is ultimately determined by the amount of cash flow that the investors have available. (NASDAQ:AMKR). Fny Managed Accounts Lc has invested 0.01% in Amkor Technology, Inc.
Once the concept of beta is understood, an investor can intuitively determine whether or not a particular stock has a high or low beta.